New York State Common Retirement Fund Reduces Holdings in Exponent, Inc. (NASDAQ:EXPO)

New York State Common Retirement Fund lessened its holdings in Exponent, Inc. (NASDAQ:EXPOFree Report) by 11.1% during the 4th quarter, Holdings Channel reports. The firm owned 28,629 shares of the business services provider’s stock after selling 3,561 shares during the quarter. New York State Common Retirement Fund’s holdings in Exponent were worth $2,520,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Asset Management One Co. Ltd. purchased a new stake in Exponent in the 4th quarter valued at approximately $4,340,000. Fenimore Asset Management Inc. increased its position in Exponent by 62.8% during the 4th quarter. Fenimore Asset Management Inc. now owns 172,868 shares of the business services provider’s stock worth $15,219,000 after purchasing an additional 66,664 shares in the last quarter. Assenagon Asset Management S.A. raised its stake in Exponent by 261.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 56,510 shares of the business services provider’s stock valued at $4,975,000 after purchasing an additional 40,886 shares during the last quarter. Natixis Advisors L.P. lifted its holdings in Exponent by 2.2% in the 3rd quarter. Natixis Advisors L.P. now owns 35,515 shares of the business services provider’s stock valued at $3,040,000 after purchasing an additional 767 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Exponent by 3.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 466,940 shares of the business services provider’s stock valued at $39,970,000 after purchasing an additional 15,819 shares in the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Exponent Trading Up 0.2 %

EXPO stock opened at $94.68 on Wednesday. The company has a market cap of $4.79 billion, a PE ratio of 47.82 and a beta of 0.64. The stock has a 50-day moving average price of $82.08 and a two-hundred day moving average price of $82.07. Exponent, Inc. has a 12-month low of $64.61 and a 12-month high of $102.72.

Exponent (NASDAQ:EXPOGet Free Report) last issued its earnings results on Thursday, April 25th. The business services provider reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.46 by $0.13. The business had revenue of $137.21 million during the quarter, compared to analysts’ expectations of $125.98 million. Exponent had a return on equity of 28.13% and a net margin of 18.72%. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.56 EPS. Equities analysts forecast that Exponent, Inc. will post 1.92 EPS for the current fiscal year.

Exponent Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Shareholders of record on Friday, June 7th will be paid a dividend of $0.28 per share. The ex-dividend date of this dividend is Friday, June 7th. This represents a $1.12 annualized dividend and a yield of 1.18%. Exponent’s dividend payout ratio is currently 56.57%.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. StockNews.com upgraded shares of Exponent from a “sell” rating to a “hold” rating in a research report on Monday, March 4th. Truist Financial increased their price objective on shares of Exponent from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, April 29th.

View Our Latest Stock Report on Exponent

Insider Transactions at Exponent

In related news, VP Bradley A. James sold 3,528 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $95.00, for a total transaction of $335,160.00. Following the completion of the sale, the vice president now directly owns 2,030 shares of the company’s stock, valued at approximately $192,850. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, insider Eric Guyer sold 1,650 shares of the business’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $92.58, for a total transaction of $152,757.00. Following the transaction, the insider now directly owns 1,846 shares of the company’s stock, valued at $170,902.68. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Bradley A. James sold 3,528 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $95.00, for a total transaction of $335,160.00. Following the completion of the transaction, the vice president now owns 2,030 shares of the company’s stock, valued at $192,850. The disclosure for this sale can be found here. Insiders sold 8,558 shares of company stock valued at $753,402 over the last 90 days. Corporate insiders own 2.20% of the company’s stock.

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.